Abstract
he ability of SARS-CoV-2 to infect the gastrointestinal tract is well described. Inflammatory bowel diseases (IBD) are believed to represent a disorganised immune response in genetically predisposed individuals, which are triggered by various environmental factors, notably infections. Here we report a case of chronic watery diarrhoea that was triggered by a SARS-CoV-2 infection. The work-up confirmed a new diagnosis of lymphocytic colitis, and the patient responded favourably to a course of oral budesonide. Clinicians should become vigilant to the possibility of triggered IBD in patients with persistent diarrhoea following a SARS-CoV-2 infection.Citation
Nassar IO, Langman G, Quraishi MN, Sharma N. SARS-CoV-2-triggered lymphocytic colitis. BMJ Case Rep. 2021 Aug 24;14(8):e243003. doi: 10.1136/bcr-2021-243003Type
ArticleOther
Additional Links
https://casereports.bmj.com/PMID
34429288Journal
BMJ Case ReportsPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/bcr-2021-243003